147 related articles for article (PubMed ID: 15327403)
41. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
Roux S; Bühler M; Clozel JP
J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
[TBL] [Abstract][Full Text] [Related]
42. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
43. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
44. Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms.
Griffin KA; Picken M; Giobbie-Hurder A; Bidani AK
Kidney Int; 2003 Feb; 63(2):607-16. PubMed ID: 12631125
[TBL] [Abstract][Full Text] [Related]
45. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
[TBL] [Abstract][Full Text] [Related]
46. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
47. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
Castoldi G; di Gioia CR; Bombardi C; Maestroni S; Carletti R; Steckelings UM; Dahlöf B; Unger T; Zerbini G; Stella A
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1123-31. PubMed ID: 25186297
[TBL] [Abstract][Full Text] [Related]
48. Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease.
Nutahara K; Higashihara E; Horie S; Kamura K; Tsuchiya K; Mochizuki T; Hosoya T; Nakayama T; Yamamoto N; Higaki Y; Shimizu T
Nephron Clin Pract; 2005; 99(1):c18-23. PubMed ID: 15637459
[TBL] [Abstract][Full Text] [Related]
49. Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats.
Toblli JE; Ferder L; Angerosa M; Inserra F
Hypertension; 1999 Oct; 34(4 Pt 2):854-8. PubMed ID: 10523373
[TBL] [Abstract][Full Text] [Related]
50. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
[TBL] [Abstract][Full Text] [Related]
51. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil.
Nebe B; Holzhausen C; Rychly J; Urbaszek W
Cardiovasc Drugs Ther; 2002 May; 16(3):183-93. PubMed ID: 12374895
[TBL] [Abstract][Full Text] [Related]
52. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury.
Park JH; Park J; Hwang SH; Han H; Ha H
Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642
[TBL] [Abstract][Full Text] [Related]
53. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[TBL] [Abstract][Full Text] [Related]
54. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney.
Mankhey RW; Wells CC; Bhatti F; Maric C
Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R769-77. PubMed ID: 16931652
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
56. Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats.
Lacolley P; Poitevin P; Koen R; Levy BI
J Hypertens; 1998 Mar; 16(3):349-55. PubMed ID: 9557928
[TBL] [Abstract][Full Text] [Related]
57. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
[TBL] [Abstract][Full Text] [Related]
58. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
Stangenberg S; Saad S; Schilter HC; Zaky A; Gill A; Pollock CA; Wong MG
Sci Rep; 2018 Jun; 8(1):9423. PubMed ID: 29930330
[TBL] [Abstract][Full Text] [Related]
59. The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy.
Huang C; Zhang L; Shi Y; Yi H; Zhao Y; Chen J; Pollock CA; Chen XM
PLoS One; 2018; 13(2):e0192800. PubMed ID: 29425253
[TBL] [Abstract][Full Text] [Related]
60. The Effect of Calcium Channel Blockers on Moderate or Severe Albuminuria in Diabetic, Hypertensive Patients.
Cativo EH; Lopez PD; Cativo DP; Atlas SA; Rosendorff C
Am J Med; 2021 Jan; 134(1):104-113.e3. PubMed ID: 32645341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
